APA (7th ed.) Citation

R, B., P, M., G, A., S, C., N, C. P., A, P., . . . P, M. (2023). Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. Gut, 72(6), 1186. https://doi.org/10.1136/gutjnl-2022-327216

Chicago Style (17th ed.) Citation

R, Burm, et al. "Novel Prime-boost Immune-based Therapy Inhibiting Both Hepatitis B and D Virus Infections." Gut 72, no. 6 (2023): 1186. https://doi.org/10.1136/gutjnl-2022-327216.

MLA (9th ed.) Citation

R, Burm, et al. "Novel Prime-boost Immune-based Therapy Inhibiting Both Hepatitis B and D Virus Infections." Gut, vol. 72, no. 6, 2023, p. 1186, https://doi.org/10.1136/gutjnl-2022-327216.